Investor
Relations
A+ / A-

Raporty

6/2014 Significant agreement with the National Health Fund

The Management Board of Centrum Medyczne ENEL-MED S.A. would like to inform you that on 06 February 2014, the company received the signed annex to the long-term agreement with National Health Fund – Masovian Voivodeship Branch in Warsaw, laying down terms of financing of healthcare services such as ambulatory specialised care – high-cost ambulatory diagnostic services for 2014. As a result of the aforementioned annex, the value of agreements concluded between the Company and the National Health Fund since publication of Current Report No. 1/2014 on 14 January 2014 reached PLN 7,995,320.20 net, and thus exceeded the threshold of 10% of the company’s equity.
In the period analysed, the largest agreement concluded with the National Health Fund was the aforementioned annex which the company received on 06 February 2014.

The subject matter of the annex concluded with the Masovian Voivodeship Branch in Warsaw is the provision of diagnostic services in the field of computed tomography, magnetic resonance, gastroscopy and colonoscopy at the Zacisze Diagnostic Laboratory in Warsaw, computed tomography at the Laboratory in Wołomin, and magnetic resonance and computed tomography at the Bielany Diagnostic Centre in Warsaw. The annex, which extends the long-term agreement concluded for the period from 01 January 2011 to 31 December 2014, sets forth the value of the agreement for 2014, which is PLN 5,170,185.00 net, maximum.

The agreement provides for the following contractual penalties for the company:
  1. In the case of non-performance or improper performance of the agreement due to fault of the Service Provider, the Fund Branch can impose a contractual penalty on the Service Provider.
  2. In the case of issuing prescriptions to unauthorised persons or in unjustified instances, the Fund Branch can impose on the Service Provider a contractual penalty equivalent to the undue reimbursement of prices of medicinal product made on the basis of the prescriptions plus statutory interest accrued since the date of the reimbursement.
  3.  In the case of issuing orders for the supply of medical devices issued based on the order, referred to in the regulations issued pursuant to Article 38 section 4 of the Act on reimbursement of drugs, foodstuffs intended for particular nutritional uses and medical devices, financed in whole or in a part by the National Health Funds, to unauthorised persons or in unjustified instances, the Fund Branch can impose on the Service Provider a contractual penalty equivalent to the amount of the undue financing plus statutory interest accrued since the date of the reimbursement.
  4. In the case of non-fulfilling the duty pertaining to obtaining, at the responsible Fund Branch, the authorisation to use the e-WUŚ service in order to ensure that service recipients are able to exercise their rights under Article 50 section 3 of the Act of 27 August 2004 on healthcare services financed from public funds, the Fund Branch can impose on the Service Provider a contractual penalty of 1% of the value of obligations set in the agreement.